Honestly I think it's more speculation than actual shortage. TSMC is a bottleneck sure, but the bigger issue is demand side FOMO. Companies hoarding GPUs without clear ROI, hyperscalers building for projected demand that may never come. Feels a lot like the fiber optics overbuild in the early 2000s.
The psilocybin data tells a similar story. One or two sessions outperforming months of conventional meds. The fact that both LSD and psilocybin work on neuroplasticity probably isn't a coincidence. Hope regulators don't drag their feet on this for another decade.
As someone that has done mushrooms a dozen or so times, I would never ever take them when I’m anxious or depressed. That’s a sure fire way to have a horrible trip. Maybe these are referring to pretty small doses.
Fair point about set and setting, taking a big dose when you're in a bad place is asking for trouble. But the research and most microdosing protocols are talking about way smaller amounts, like 0.15-0.3g every other day. That's well below the 1.5-2g where you actually start tripping. Personally microdosing in that range has helped me a lot with focus and creativity, no trip, no weirdness, just a subtle shift. It's a completely different thing from what people usually imagine when they hear mushrooms.
The data here matches what I've seen firsthand. Working remote I get roughly 30% more actual work done, mostly because deep focus is way easier to protect. The productivity argument for RTO always felt backwards to me.
reply